Effects of Carbamylated Erythropoietin Fusion Protein on Parkinson's Disease Model of Rat

被引：0
|
作者：
Tayra, J. T. [1 ]
Kameda, M. [1 ]
Yasuhara, Y. [1 ]
Wang, F. [1 ]
Kikuchi, Y. [1 ]
Liang, H. [1 ]
Shinko, A. [1 ]
Wakamori, T. [1 ]
Miyoshi, Y. [1 ]
Date, I. [1 ]
机构：
[1] Okayama Univ, Dept Neurol Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan
来源：
CELL TRANSPLANTATION | 2011年 / 20卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
引用
收藏
页码：588 / 588
页数：1
相关论文
共 50 条
  • [1] The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease
    Tayra, Judith Thomas
    Kameda, Masahiro
    Yasuhara, Takao
    Agari, Takashi
    Kadota, Tomohito
    Wang, Feifei
    Kikuchi, Yoichiro
    Liang, Hanbai
    Shinko, Aiko
    Wakamori, Takaaki
    Vcelar, Brigitta
    Weik, Robert
    Date, Isao
    BRAIN RESEARCH, 2013, 1502 : 55 - 70
  • [2] Positive effects of erythropoietin on a rat model of Parkinson's disease
    Solmaz, V.
    Aksoy, D.
    Erbas, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 363 - 363
  • [3] Positive effects of Erythropoietin on a rat model of Parkinson's disease
    Solmaz, V.
    Aksoy, D.
    Erbas, O.
    JOURNAL OF NEUROLOGY, 2014, 261 : S244 - S244
  • [4] Effects of erythropoietin in the executive control in Parkinson's disease
    Perez-Bocourt, V.
    Vega, M. L. B.
    Rodriguez, V. R.
    MOVEMENT DISORDERS, 2012, 27 : S48 - S48
  • [5] Neurorescue effects of VEGF on a rat model of Parkinson's disease
    Yasuhara, T
    Shingo, T
    Muraoka, K
    Kameda, M
    Agari, T
    Ji, YW
    Hayase, H
    Hamada, H
    Borlongan, CV
    Date, I
    BRAIN RESEARCH, 2005, 1053 (1-2) : 10 - 18
  • [6] Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat
    Barneoud, P
    Mazadier, M
    Miquet, JM
    Parmentier, S
    Dubedat, P
    Doble, A
    Boireau, A
    NEUROSCIENCE, 1996, 74 (04) : 971 - 983
  • [7] Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease
    Harvey, BK
    Mark, A
    Chou, J
    Chen, GJ
    Hoffer, BJ
    Wang, Y
    BRAIN RESEARCH, 2004, 1022 (1-2) : 88 - 95
  • [8] Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in a rat model of Parkinson's disease
    Xue, YQ
    Zhao, LR
    Duan, WM
    EXPERIMENTAL NEUROLOGY, 2006, 198 (02) : 595 - 595
  • [9] Mildronate as a Regulator of Protein Expression in a Rat Model of Parkinson's Disease
    Isajevs, Sergejs
    Isajeva, Darja
    Beitnere, Ulrika
    Jansone, Baiba
    Kalvinsh, Ivars
    Klusa, Vija
    MEDICINA-LITHUANIA, 2011, 47 (10): : 552 - 559
  • [10] AAV9-mediated erythropoietin gene transfer to the rat brain in a rat model of Parkinson's disease
    Xue, Y. -Q.
    Tatom, J. B.
    Jiang, L. -X.
    Zhao, L. -R.
    Klein, R. L.
    Duan, W. -M.
    CELL TRANSPLANTATION, 2008, 17 (04) : 486 - 486
12345